Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer

Lijie Simaa Department of Hematology and Oncology, The Affiliated Shaoyang Hospital, Hengyang Medical School, University of South China (Shaoyang Central Hospital), Shaoyang, ChinaView further author information

Zhongyuan Wangb Department of Pharmacy, Guizhou Provincial People’s Hospital, Guiyang, ChinaView further author information

Ling Yuc Department of Pharmacy, Guiyang Healthcare Vocational University, Guiyang, ChinaView further author information

Youli Houd Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, ChinaView further author information

Dongsheng Zhaod Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, ChinaView further author information

Bilan Luod Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, ChinaView further author information

Weike Liaod Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, ChinaView further author information

Xinfu Liua Department of Hematology and Oncology, The Affiliated Shaoyang Hospital, Hengyang Medical School, University of South China (Shaoyang Central Hospital), Shaoyang, ChinaCorrespondence[email protected]
View further author information

show all

Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date